12 Month Price Forecast For CTVA
Distance to CTVA Price Forecasts
CTVA Price Momentum
🤔 Considering Corteva (CTVA)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 8:51 PM UTC
CTVA Analyst Ratings & Price Targets
Based on our analysis of 29 Wall Street analysts, CTVA has a bullish consensus with a median price target of $70.00 (ranging from $57.00 to $75.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $62.21, the median forecast implies a 12.5% upside. This outlook is supported by 16 Buy, 7 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Bobby Burleson at Canaccord Genuity, projecting a 20.6% upside. Conversely, the most conservative target is provided by Jeffrey Zekauskas at JP Morgan, suggesting a 8.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CTVA Analyst Consensus
CTVA Price Target Range
Latest CTVA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CTVA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 7, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $72.00 |
| Feb 7, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $70.00 |
| Feb 7, 2025 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $73.00 |
| Jan 29, 2025 | Citigroup | Patrick Cunningham | Buy | Maintains | $74.00 |
| Jan 28, 2025 | Wells Fargo | Richard Garchitorena | Overweight | Maintains | $73.00 |
| Jan 21, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $64.00 |
| Jan 10, 2025 | UBS | Joshua Spector | Buy | Maintains | $73.00 |
| Jan 10, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $68.00 |
| Dec 19, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $73.00 |
| Dec 18, 2024 | Citigroup | Patrick Cunningham | Buy | Maintains | $69.00 |
| Nov 21, 2024 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $69.00 |
| Nov 20, 2024 | Wells Fargo | Richard Garchitorena | Overweight | Maintains | $67.00 |
| Nov 20, 2024 | B of A Securities | Steve Byrne | Buy | Maintains | $69.00 |
| Nov 11, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $68.00 |
| Nov 8, 2024 | Oppenheimer | Kristen Owen | Outperform | Reiterates | $70.00 |
| Nov 8, 2024 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $62.00 |
| Nov 7, 2024 | UBS | Joshua Spector | Buy | Maintains | $71.00 |
| Oct 23, 2024 | Citigroup | Patrick Cunningham | Buy | Initiates | $68.00 |
| Oct 16, 2024 | B of A Securities | Steve Byrne | Buy | Upgrade | $67.00 |
| Sep 24, 2024 | Morgan Stanley | Vincent Andrews | Overweight | Maintains | $65.00 |
Stocks Similar to Corteva Inc
The following stocks are similar to Corteva based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Corteva Inc (CTVA) Financial Data
Corteva Inc has a market capitalization of $42.81B with a P/E ratio of 51.2x. The company generates $16.64B in trailing twelve-month revenue with a 4.2% profit margin.
Revenue growth is -10.2% quarter-over-quarter, while maintaining an operating margin of -20.0% and return on equity of +2.7%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Corteva Inc (CTVA) Company Overview
About Corteva Inc
Provides agricultural seeds and crop protection solutions.
Corteva, Inc. generates revenue through two main segments: Seed and Crop Protection. The Seed segment focuses on developing advanced seeds and traits to enhance agricultural yield and resilience, while the Crop Protection segment offers a range of products designed to safeguard crops from pests and diseases, thus contributing to overall crop health.
The company serves a global agricultural input market, operating in multiple regions including North America, Latin America, Europe, and Asia. Established in 2018 and headquartered in Indianapolis, Corteva leverages digital solutions to aid farmers in decision-making and optimizing yields.
Company Information
Sector
Basic Materials
Industry
Agricultural Inputs
Employees
22,500
CEO
Mr. Charles Victor Magro B.Sc. (Chem), MBA
Country
United States
IPO Year
2019
Website
www.corteva.comCorteva Inc (CTVA) Latest News & Analysis
CTA-B offers a 6.32% yield as an investment-grade preferred stock backed by Corteva, Inc., with low leverage suggesting stable dividends and a potential 10% capital appreciation.
CTA-B's 6.32% yield and Corteva's strong financials signal reliability, while its undervaluation suggests potential for 10% capital appreciation, appealing to income-focused investors.
Corteva, Inc. (CTVA) announced mixed fourth-quarter results after market close on Wednesday.
Mixed results from Corteva may indicate volatility in performance, affecting investor confidence and stock price. Analysts may reassess future growth prospects based on these results.
Corteva, Inc. (NYSE:CTVA) will hold its Q4 2024 earnings conference call on February 6, 2024, at 9:00 AM ET, featuring key executives and analysts from various financial institutions.
The earnings call for Corteva, Inc. provides critical insights into the company's financial performance, strategic direction, and market outlook, influencing investor sentiment and stock valuation.
Corteva, Inc. (CTVA) reported Q3 earnings of $0.32 per share, below the Zacks Consensus Estimate of $0.34, but up from $0.15 per share year-over-year.
Corteva's earnings miss signals potential concerns about growth and profitability, which may impact stock performance and investor confidence moving forward.
Corteva, Inc. (CTVA) reported revenue and EPS for Q4 2024; investors should compare these figures with Wall Street estimates and year-ago performance for context.
Corteva's revenue and EPS figures relative to Wall Street estimates and prior year performance indicate financial health and growth potential, influencing investor sentiment and stock valuation.
Corteva, Inc. reported Q4 2024 results aligned with expectations, with strong volume gains in Brazil. 2025 guidance adjusted for U.S. dollar strength. Full-year results indicate stable tech demand.
Corteva's strong Q4 performance and revised 2025 guidance signal robust demand and potential currency risks, influencing future revenue and investment decisions.
Frequently Asked Questions About CTVA Stock
What is Corteva Inc's (CTVA) stock forecast for 2025?
Based on our analysis of 29 Wall Street analysts, Corteva Inc (CTVA) has a median price target of $70.00. The highest price target is $75.00 and the lowest is $57.00.
Is CTVA stock a good investment in 2025?
According to current analyst ratings, CTVA has 16 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $62.21. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CTVA stock?
Wall Street analysts predict CTVA stock could reach $70.00 in the next 12 months. This represents a 12.5% increase from the current price of $62.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Corteva Inc's business model?
Corteva, Inc. generates revenue through two main segments: Seed and Crop Protection. The Seed segment focuses on developing advanced seeds and traits to enhance agricultural yield and resilience, while the Crop Protection segment offers a range of products designed to safeguard crops from pests and diseases, thus contributing to overall crop health.
What is the highest forecasted price for CTVA Corteva Inc?
The highest price target for CTVA is $75.00 from Bobby Burleson at Canaccord Genuity, which represents a 20.6% increase from the current price of $62.21.
What is the lowest forecasted price for CTVA Corteva Inc?
The lowest price target for CTVA is $57.00 from Jeffrey Zekauskas at JP Morgan, which represents a -8.4% decrease from the current price of $62.21.
What is the overall CTVA consensus from analysts for Corteva Inc?
The overall analyst consensus for CTVA is bullish. Out of 29 Wall Street analysts, 16 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $70.00.
How accurate are CTVA stock price projections?
Stock price projections, including those for Corteva Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
